Tumor mutational burden as a predictive biomarker for molecularly matched therapy in two independent pan-cancer cohorts

被引：0
|
作者：
Jelas, I [1 ]
de Bortoli, T. [2 ]
Benary, M. [2 ]
Horak, P. [3 ]
Lamping, M. [2 ]
Schaefer, R. [2 ]
Klauschen, F. [2 ]
Tinhofer-Keilholz, I [2 ]
Leyvraz, S. [2 ]
Keller, U. [2 ]
Stenzinger, A.
Froehling, S. [3 ]
Stintzing, S. [1 ,4 ]
Kurzrock, R. [5 ]
Keilholz, U. [2 ]
Rieke, D. [2 ]
机构：
[1] Charite Univ Med Berlin, Klin Hamatol Onkol & Tumorimmunol, Berlin, Germany
[2] Charite Univ Med Berlin, Berlin, Germany
[3] NCT Heidelberg, Heidelberg, Germany
[4] Univ Klinikum Heidelberg, Heidelberg, Germany
[5] Worldwide Innovat Network WIN Assoc WIN Consortiu, Villejuif, France
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V563
引用
收藏
页码：89 / 90
页数：2
相关论文
共 50 条
  • [11] Assessment of the tumor mutational burden in a large cohort of Chinese advanced pan-cancer patients
    Liu, Ping
    Cui, Longgang
    Cai, Shangli
    CANCER RESEARCH, 2020, 80 (16)
  • [12] TMBcalc: a computational pipeline for identifying pan-cancer Tumor Mutational Burden gene signatures
    Privitera, Grete Francesca
    Alaimo, Salvatore
    Caruso, Anna
    Ferro, Alfredo
    Forte, Stefano
    Pulvirenti, Alfredo
    FRONTIERS IN GENETICS, 2024, 15
  • [13] Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors
    Sha, Dan
    Jin, Zhaohui
    Budczies, Jan
    Kluck, Klaus
    Stenzinger, Albrecht
    Sinicrope, Frank A.
    CANCER DISCOVERY, 2020, 10 (12) : 1808 - 1825
  • [14] Pan-Cancer assessment of tumor mutational burden using a comprehensive genomic profiling assay.
    Nichol, Donna
    Jones, Sian
    Angiouli, Samuel V.
    Keefer, Laurel
    Nesselbush, Monica
    Sengamalay, Naomi
    White, James
    Simmons, John
    Diaz, Luis A.
    Velculescu, Victor E.
    Sausen, Mark
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [15] Pan-cancer analysis of heterogeneity of tumor mutational burden and genomic mutation under treatment pressure
    Huang, R. J.
    Huang, Y. S.
    An, N.
    Hu, J. J.
    Wu, C. Y.
    Chen, Y. X.
    Chen, J. Y.
    Zhao, Q.
    Xu, R. H.
    Yuan, S. Q.
    Wang, F.
    ESMO OPEN, 2024, 9 (07)
  • [16] Circulating Tumor DNA: A Pan-Cancer Biomarker in Solid Tumors with Prognostic and Predictive Value
    Hitchen, Nadia
    Shahnam, Adel
    Tie, Jeanne
    ANNUAL REVIEW OF MEDICINE, 2025, 76 : 207 - 223
  • [17] Tumor mutational burden as a predictive biomarker for checkpoint inhibitor immunotherapy
    Lee, Mark
    Samstein, Robert M.
    Valero, Cristina
    Chan, Timothy A.
    Morris, Luc G. T.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (01) : 112 - 115
  • [18] Characteristics of Pan-Cancer Patients With Ultrahigh Tumor Mutation Burden
    Yuan, Hong
    Ji, Jun
    Shi, Min
    Shi, Yan
    Liu, Jing
    Wu, Junwei
    Yang, Chen
    Xi, Wenqi
    Li, Qingyuan
    Zhu, Wei
    Li, Jingjie
    Gong, Xiaoli
    Zhang, Jun
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [19] Development of a pan-cancer NGS assay for detection of tumor mutational burden and targeted biomarkers from FFPE samples
    Cyanam, Dinesh
    Mittal, Vinay
    Khazanov, Nickolay
    Williams, Paul
    Au-Young, Janice
    Bee, Gary
    El-Difrawy, Sameh
    Ewing, Aren
    Kilzer, Jennifer
    Kraltcheva, Anelia
    Myrand, Scott
    Tseng, Yu-Ting
    Van Loy, Cristina
    Wong-Ho, Elaine
    Yang, Chenchen
    Cyanam, Dinesh
    Bandla, Santhoshi
    Tom, Warren
    Sadis, Seth
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [20] Pan-Cancer Survey of Tumor Mass Dormancy and Underlying Mutational Processes
    Wiecek, Anna Julia
    Jacobson, Daniel Hadar
    Lason, Wojciech
    Secrier, Maria
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
12345